Here we are at the midpoint of 2006 already. The first half stock market doesn't look pretty! The Dow is up a modest 4%. Two months ago, the Dow was up twice that level but took a tumble in May falling sharply in June and beginning to bounce back in July. The NASDAQ has really taken a hit in these first 6 months, having dropped 2%.
We all know about continue......Full article >>>
$2.7 billion. Imagine what will happen with Pfizer's Lipitor with last year's sales of $13 billion (granted this is worldwide and Pfizer's patent expiration in different parts of the world varies).
More recently, during the last 3 years, Big Pharma has experimented with a different formula called "authorized generics". Under this scenario, in advance of patent expiration, Big Pharma has ......Full article >>>
, and the completion of the Boston Scientific/Abbott Lab's acquisition of Guidant (with Abbott acquiring an equity chunk of Boston Scientific in the process). Of note, in the last week was the disposal by Pfizer of its consumer products business to J&J for over $7 billion. This includes products like Listerine and other products Pfizer had obtained in the Warner-Lambert acquisition along with Pfiz......Full article >>>
|7. Merck (MRK)||$36.43||$31.99||+14%||$ 79.5|
|8. Abbott Labs (ABT)||$43.61||$46.50||<4%>||$ 66.6|
|9. Eli Lilly (LLY)||$55.27||$56.77||<3%>||$ 62.5|
|10. Wyeth (WYE)||$44.4......|
Full article >>>
han the NASDAQ and AMEX Biotech indices. Not a pretty first half!
Big biotech stock performance 2006
|Biotech Company/Ticker||Stock Price June 30, 2006||Stock Price Jan.2, 2006||%Change||Market Cap(S B)|
|NASDAQ Biotech Index||742.87||795.32......|
Full article >>>
period and shut for 1-2 years. The current IPO window has lingered open since the 4th quarter of 2004; however it has not been a strong market, with low initial pricings and valuations. Nevertheless, it continues to remain open! We will look at this further in weeks to come!
One issue that both Big Pharma and biotech companies face: increasing resistance to high pricing on new ......
Full article >>>
Source:wistechnology.com By Michael Rosen 07/03/06
Related biology technology :
1. The Genesis of Gendicine: The Story Behind the First Gene Therapy
2. Business Objects to acquire La Crosse-based Firstlogic
3. Pitney Bowes and Firstlogic cancel acquisition plans
4. Tech Digest: Fiserv, IMS, Honeywell HomMed, Firstlogic
5. Tech Digest: Firstlogic, Fiserv, Red Prairie, Spectrum Brands, Associated Bank
6. J.J. Keller, Modine Manufacturing, Gustave A. Larson Co., Esker, Firstlogic, Software One
7. Pitney Bowes to acquire Firstlogic
8. Firstlogic, Informatica expand OEM partnership
9. Crate and Barrel deploys Firstlogics Information Quality Suite
10. Merkle selects Firstlogic data quality software
11. First pieces of Antarctic deep-space particle detector are in place
(Date:10/13/2015)... Applied BioMath ( www.appliedbiomath.com ), a computational ... the drug invention process, announced that it will sponsor ... 20-22, 2015 in Boston , MA. ... CEO of Applied BioMath, will present "QSP approaches enabling quantitative ... trials" on Wednesday October 21st 2015 at 12:30PM. ...
(Date:10/13/2015)... -- Q BioMed Inc (OTC: QBIO), ... a strategic relationship with Wombat Capital, Ltd., a ... France based strategic and scientific advisory firm.. ... collaborative arrangement gives Q BioMed and its stakeholders access ... as long established pharmaceutical industry relationships. The advisors within ...
(Date:10/13/2015)... ... 2015 , ... Clinovo recently appointed Jeff Parr and Ed Donaldson to its ... solutions business. , Jeff Parr has spent the past decade providing quality management software ... Fisher, and Ab Sciex to name a few. He is based in Salt ...
(Date:10/12/2015)... , Oct. 12, 2015 Amgen (NASDAQ: AMGN ... from an exploratory sub-study of the previously reported romosozumab Phase ... an oral plenary session at the American Society for Bone ... Seattle . 2 --> ... sub-study data showed that, at month 12, the investigational bone-forming ... Breaking Biology Technology:
(Date:10/5/2015)... , October 5, 2015 ... company update for NXT-ID, Inc. (NASDAQ: NXTD ), ... commerce market. --> http://soundview.co ) ... Inc. (NASDAQ: NXTD ), a biometric authentication company ... SoundView Technology Group ( http://soundview.co ) ...
(Date:9/30/2015)... global glucose monitoring device and diabetes management market is valued ... on the industry from Kalorama Information. Sales in the traditional glucose ... continuous glucose monitoring and sensor segment, according to the healthcare ... in its latest report, The Global Glucose Monitoring Market ... , ...
(Date:9/28/2015)... SAN FRANCISCO , September 28, 2015 ... size is expected to reach USD 12.03 billion by ... to 2020. Technological advancements such as Backside Illumination (BSI) ... revenue growth over the forecast period. ... the back of the chip to reduce loss and, ... Breaking Biology News(10 mins):